British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids

MD Russell, M Dey, J Flint, P Davie, A Allen… - …, 2023 - academic.oup.com
Background The rationale behind this update of the 2016 British Society for Rheumatology
(BSR) guidelines on prescribing anti-rheumatic drugs in pregnancy and breastfeeding [1, 2] …

Uterine natural killer cells: from foe to friend in reproduction

I Díaz-Hernández, D Alecsandru… - Human reproduction …, 2021 - academic.oup.com
BACKGROUND Recurrent miscarriage and pre-eclampsia are common reproductive
disorders, but their causes are often unknown. Recent evidence has provided new insight …

BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—Part I: standard and biologic disease modifying anti-rheumatic drugs and …

J Flint, S Panchal, A Hurrell, M van de Venne… - …, 2016 - academic.oup.com
Julia Flint1, Sonia Panchal2, Alice Hurrell3, Maud van de Venne4, Mary Gayed5, Karen
Schreiber6, 7, Subha Arthanari8, Joel Cunningham3, Lucy Flanders3, Louise Moore9, Amy …

VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence …

SM Bates, IA Greer, S Middeldorp, DL Veenstra… - Chest, 2012 - Elsevier
Background The use of anticoagulant therapy during pregnancy is challenging because of
the potential for both fetal and maternal complications. This guideline focuses on the …

Venous thromboembolism and antithrombotic therapy in pregnancy

WS Chan, E Rey, NE Kent, T Corbett, M David… - Journal of obstetrics and …, 2014 - Elsevier
Objective To present an approach, based on current evidence, for the diagnosis, treatment,
and thromboprophylaxis of venous thromboembolism in pregnancy and postpartum …

[HTML][HTML] Aspirin plus heparin or aspirin alone in women with recurrent miscarriage

SP Kaandorp, M Goddijn… - … England Journal of …, 2010 - Mass Medical Soc
Background Aspirin and low-molecular-weight heparin are prescribed for women with
unexplained recurrent miscarriage, with the goal of improving the rate of live births, but …

Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia

PG De Jong, S Kaandorp, M Di Nisio… - Cochrane Database …, 2014 - cochranelibrary.com
Background Since hypercoagulability might result in recurrent miscarriage, anticoagulant
agents could potentially increase the chance of live birth in subsequent pregnancies in …

Recurrent miscarriage: diagnostic and therapeutic procedures. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry Number 015/050)

B Toth, W Würfel, M Bohlmann… - Geburtshilfe und …, 2018 - thieme-connect.com
Ziel Offizielle Leitlinie der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe
(DGGG), der Österreichischen Gesellschaft für Gynäkologie und Geburtshilfe (ÖGGG) und …

Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational …

MA Rodger, WM Hague, SR Kahn, A Karovitch… - The Lancet, 2014 - thelancet.com
Background Thrombophilias are common disorders that increase the risk of pregnancy-
associated venous thromboembolism and pregnancy loss and can also increase the risk of …

Immunological risk factors in recurrent pregnancy loss: guidelines versus current state of the art

K Vomstein, K Feil, L Strobel, A Aulitzky… - Journal of clinical …, 2021 - mdpi.com
Around 1–5% of all couples experience recurrent pregnancy loss (RPL). Established risk
factors include anatomical, genetic, endocrine, and hemostatic alterations. With around 50 …